Stock Comparison
ABT vs PODD
Abbott Laboratories and Insulet Corporation side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$163.94B
$10.65B
P/E (TTM)
26.4
35.9
Forward P/E
17.2
24.8
Price/Sales
3.6
3.8
Price/Book
3.2
8.2
EV/EBITDA
16.1
19.7
Dividend Yield
2.62%
—
Profitability
Net Margin
13.90%
10.40%
Operating Margin
13.50%
16.00%
Return on Equity
12.30%
23.00%
Return on Assets
5.59%
9.74%
Growth (YoY)
Revenue Growth
7.80%
33.90%
Earnings Growth
-19.70%
159.00%
Price & Risk
Beta
0.6
1.1
52-Week High
$135.34
$354.88
52-Week Low
$81.97
$138.79
Analyst Target
$116.54
$240.25
Compare ABT and PODD your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.